Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 72Unknown 44Recruiting 42Terminated 22Not yet recruiting 12Active not recruiting 6Withdrawn 5Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 32Neoplasms 28Colorectal Neoplasms 19Prostatic Neoplasms 16Lung Neoplasms 13Leukemia, Myeloid, Acute 12Glioblastoma 12Stomach Neoplasms 10Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Melanoma 8Glioma 8Brain Neoplasms 8Rectal Neoplasms 7Carcinoma, Hepatocellular 7Ovarian Neoplasms 6Neoplasm Metastasis 6Hematologic Neoplasms 6Uterine Cervical Neoplasms 5Polycystic Ovary Syndrome 5Myelodysplastic Syndromes 5Multiple Myeloma 5Esophageal Neoplasms 5Carcinoma, Renal Cell 5Triple Negative Breast Neoplasms 4Lymphoma, B-Cell 4Lymphoma 4Depression 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × OTHER × Lymphoma, T-Cell, Peripheral × Clear all
NCT04828174 2023-11-29

Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 1 Suspended
9 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡